Payer-based DB 13M individuals

Accumulated number of insured members from Jan 2005 to Jun 2021

Claim × PRO 700K individuals

Number of PRO panels, who can be connected to Payer-based DB

Hospital-based DB 463hospitals

Number of medical institutions with contracts

EMR DB
(Clinical Lab test)
28hospitals

Number of medical institutions where laboratory values can be obtained

Data infrastructure/
Analysis platform
50+ companies

Number of companies with full access license to our databases/analysis platform

Publications 404articles

Number of articles published using our databases

*All as of the end of Sep 2021

Patient ranking

Preliminary disease

(Payer-based DB) July 2020 to June 2021

Name

Number of patients diagnosed

  1. J30 Vasomotor rhinitis and allergic rhinitis <Nasal Allergy> 2,179,381
  2. E78 Lipoprotein <Protein> metabolic disorders and other lipemias 908,162
  3. L20 Atopic dermatitis 572,764
  4. E10-E14 Diabetes mellitus 491,560
  5.                         
  6. H40 Glaucoma 308,602

*Number of unique patients with at least 1 diagnosis/prescription during the period

Autoimmune disease

(Payer-based DB) July 2020 to June 2021

Name

Number of patients diagnosed

  1. M06 Other rheumatoid arthritis 56,351
  2. L40 Psoriasis <Tinea> 41,715
  3. K51 Ulcerative colitis 25,735
  4. M32 Systemic lupus erythematodes <systemic lupus erythematosus> <SLE> 11,744
  5. K50 Crohn's disease [regional enteritis] 5,600

*Number of unique patients with at least 1 diagnosis/prescription during the period

Biologic drugs

(Payer-based DB) July 2020 to June 2021

Name

Number of patients prescribed

  1. Humira (L04B-) 2,935
  2. Dupixent (L04C-) 2,669
  3. Remicade (L04B-) 2,473
  4. Actemra (M01C-) 2,379
  5. Simponi (L04B-) 1,127

*Number of unique patients with at least 1 diagnosis/prescription during the period

Female disease

(Payer-based DB) July 2020 to June 2021

Name

Number of patients diagnosed

  1. D25 Uterine leiomyoma 161,161
  2. N92 Menorrhagia, polymenorrhea, and menstrual irregularity 95,900
  3. N80 Endometriosis 93,978
  4. C50 Malignant breast neoplasm <Tumor> 44,968
  5. C53 Malignant neoplasm of the uterine cervix <Tumor> 5,702
  6. C56 Malignant neoplasm of the ovary <Tumor> 5,255

*Number of unique patients with at least 1 diagnosis/prescription during the period